The National Cancer Institute Small Business Innovation Research Development Center (NCI SBIR) is interested in connecting SBIR- and STTR-funded companies with potential investors and strategic partners to continue the research and commercialization efforts initially funded by NCI. To help facilitate the connection, NCI SBIR has been organizing Investor Initiatives as a means to connect companies with targeted investors and strategic partners on a regular basis throughout the year. The NCI SBIR Investor Initiatives program provides selected SBIR companies with resources to present at national showcases where they can explore partnering and investment opportunities.
Participation in the Investor Initiatives will be determined on a competitive basis as determined using an annual application process. This application is intended to be used for all of NCI’s Investor Initiatives starting in late summer 2022 through spring 2023. NCI also uses the outcomes of this program to recommend companies to the NIH (SEED) Company Showcase Program. Based on external reviewer feedback of submitted applications, selected companies will receive financial assistance to cover presentation and registration costs at one industry hosted investor showcase. In the last six years, more than 170 NCI SBIR-funded companies were selected to present at various conferences such as BIO, BioNetwork, MedTech Strategist events, Life Sciences Summit, PMWC, and RESI.
Application Deadline: EOD Tuesday, March 1, 2022
*Incomplete applications will be returned.*
Showcases in which the NCI SBIR program has participated in the past or is considering in the future include but are not limited to:
All small businesses who have received a Phase I NCI SBIR/STTR award in FY2020 or later or received a Phase II NCI SBIR/STTR award in FY2018 or later are eligible to apply. Please note that each company can submit only one application form. If your company has received multiple awards, select the project/product with the greatest commercial potential for an investor event. Companies in all developmental stages are welcome to apply.
Why should you apply?
Note: After you submit your application and during the review process, we may reach out to ask for you to submit a short video pitch that will help us make our final decisions.
NCI SBIR Development Center Points of Contact: